Palazestrant 500 µg | ≥98% Cayman Chemical An ERα antagonist More Information Supplier Page × Palazestrant
Palazestrant 5 mg | ≥98% Cayman Chemical An ERα antagonist More Information Supplier Page × Palazestrant
Palazestrant 1 mg | ≥98% Cayman Chemical An ERα antagonist More Information Supplier Page × Palazestrant
PF-06835919 5 mg | ≥98% Cayman Chemical A KHK-C inhibitor More Information Supplier Page × PF-06835919
PF-06835919 25 mg | ≥98% Cayman Chemical A KHK-C inhibitor More Information Supplier Page × PF-06835919
PF-06835919 10 mg | ≥98% Cayman Chemical A KHK-C inhibitor More Information Supplier Page × PF-06835919
PF-06835919 1 mg | ≥98% Cayman Chemical A KHK-C inhibitor More Information Supplier Page × PF-06835919
DS-3032 5 mg | ≥98% Cayman Chemical An inhibitor of the MDM2-p53 protein-protein interaction More Information Supplier Page × DS-3032
DS-3032 10 mg | ≥98% Cayman Chemical An inhibitor of the MDM2-p53 protein-protein interaction More Information Supplier Page × DS-3032
DS-3032 1 mg | ≥98% Cayman Chemical An inhibitor of the MDM2-p53 protein-protein interaction More Information Supplier Page × DS-3032
